| 1 |
|
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus
|
Plows, D. J. Marriott, A. C. Simpson, A. Tolley, K. P.
|
Butterworths
|
1996
|
|
|
|
| 2 |
|
Immune responses following cocktails of inactivated measles vaccine and Arachis hypogaea L. (groundnut) or Cocos nucifera L. (coconut) oils adjuvant
|
Eghafona, N. O.
|
Butterworths
|
1996
|
|
|
|
| 3 |
|
Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems
|
Jennings, R. Hassan, Y. Brewer, J. M. Alexander, J.
|
Butterworths
|
1996
|
|
|
|
| 4 |
|
Immune responses of lambs to the fusion (F) glycoprotein of bovine respiratory syncytial virus expressed on insect cells infected with a recombinant baculovirus
|
Sharma, A. K
|
Butterworths
|
1996
|
|
|
|
| 5 |
|
Immune response to a booster dose of enhanced potency inactivated polio vaccine administered in association with HBV vaccine in adolescents
|
Pregliasco, F
|
Butterworths
|
1996
|
|
|
|
| 6 |
|
Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine
|
Khawplod, P
|
Butterworths
|
1996
|
|
|
|
| 7 |
|
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen
|
Londo�, L. P
|
Butterworths
|
1996
|
|
|
|
| 8 |
|
Immunization against diphtheria with special emphasis on immunization ofadults
|
Galazka, A. M
|
Butterworths
|
1996
|
|
|
|
| 9 |
|
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection
|
Oliveira, S. C
|
Butterworths
|
1996
|
|
|
|
| 10 |
|
Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy
|
O'Dempsey, T. J. D
|
Butterworths
|
1996
|
|
|
|
| 11 |
|
Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100
|
Idaenpaeaen-Heikkilae, I
|
Butterworths
|
1996
|
|
|
|
| 12 |
|
Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
|
Holzer, B. R
|
Butterworths
|
1996
|
|
|
|
| 13 |
|
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults
|
Bruguera, M
|
Butterworths
|
1996
|
|
|
|
| 14 |
|
Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route
|
Fisch, A
|
Butterworths
|
1996
|
|
|
|
| 15 |
|
Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) indogs
|
Fekadu, M
|
Butterworths
|
1996
|
|
|
|
| 16 |
|
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
|
Klugman, K. P
|
Butterworths
|
1996
|
|
|
|
| 17 |
|
Immunogenicity of a fusion protein linking the beta subunit carboxyl terminal peptide (CTP) of human chorionic gonadotropin to the B subunit of Escherichia coli heat-labile enterotoxin (LTB)
|
Rock, E. P
|
Butterworths
|
1996
|
|
|
|
| 18 |
|
Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers"vaccines with the immune response
|
Bienzle, U
|
Butterworths
|
1996
|
|
|
|
| 19 |
|
Immunogenicity of a peptide from a major neutralising determinant of thefeline immunodeficiency virus surface glycoprotein
|
Rigby, M. A
|
Butterworths
|
1996
|
|
|
|
| 20 |
|
Immunogenic potential of rgp120 from African HIV-1 subtype A
|
Xie, J.-M
|
Butterworths
|
1996
|
|
|
|